Financhill
Back

Simulations Plus Quote, Financials, Valuation and Earnings

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
47

SLP
Simulations Plus

Last Price:
$28.64
Seasonality Move:
22.36%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Simulations Plus Price Quote

$28.64
+0.06 (+-0.83%)
(Updated: December 21, 2024 at 5:47 AM ET)

Simulations Plus Key Stats

Sell
47
Simulations Plus (SLP) is a Sell

Day range:
$28.45 - $29.79
52-week range:
$27.07 - $51.22
Dividend yield:
0.84%
P/E ratio:
58.33
P/S ratio:
8.29
P/B ratio:
3.14%

Volume:
350.1K
Avg. volume:
211.8K
1-year change:
-34.21%
Market cap:
$573.5M
Revenue:
$70M
EPS:
$0.48

How Much Does Simulations Plus Make?

Data Unavailable

Is Simulations Plus Growing As A Company?

Data Unavailable

Simulations Plus Stock Price Performance

  • Did Simulations Plus Stock Go Up Last Month?
    Simulations Plus share price went up by 3.63% last month
  • Did SLP's Share Price Rise Over The Last Year?
    SLP share price fell by -34.21% over the past 1 year

What Is Simulations Plus 52-Week High & Low?

Simulations Plus Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Simulations Plus?

Data Unavailable

Is Simulations Plus Cash Flow Positive?

Data Unavailable

Simulations Plus Return On Invested Capital

Data Unavailable

Simulations Plus Earnings Date & Stock Price

Simulations Plus Competitors

  • Who Are Simulations Plus's Competitors?
    Below is a list of companies who compete with Simulations Plus or are related in some way:
    • Optimus Healthcare Svcs Inc (OHCS)
    • Schrodinger Inc (SDGR)
    • Veeva Systems Inc (VEEV)
    • Nano Mobile Healthcare Inc (VNTH)
    • Xsovt Brands Inc (XSVT)

Simulations Plus Dividend Yield

Data Unavailable

Simulations Plus Analyst Estimates

YoY Growth Past Surprise
EPS: -25% 21.27%
Revenue: 14.23% 3.49%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable